Physician profile
Renee M Stein
NPI 1023064284
$4,187.91
in general payments reported to CMS, 2019-2025
34 companies · $700 in 2025
The $700 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $775 · 2020: $116 · 2021: $644 · 2022: $845 · 2023: $651 · 2024: $457 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,808.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $692.57 | 2019-2025 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $460.32 | 2021-2025 | |
| Astellas Pharma US INC | $405.58 | 2019-2024 | Veozah, Myrbetriq |
| Allergan, INC. | $264.43 | 2019-2020 | |
| Exact Sciences Corporation | $248.45 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $230.86 | 2019-2025 | |
| Hologic Sales and Service, LLC | $211.93 | 2021-2025 | Thinprep 2000 Processor, Third Wave, Aptima |
| Organon LLC | $193.54 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $172.22 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $159.47 | 2023-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $145.04 | 2022 | |
| Meditrina | $141.75 | 2021-2025 | |
| Duchesnay USA Incorporated | $110.98 | 2019 | |
| Myovant Sciences INC. | $85.29 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $76.67 | 2019-2025 | Gardasil 9 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $75.67 | 2022-2025 | Slynd |
| Pfizer INC. | $68.94 | 2023-2025 | |
| Optumhealth Care Solutions, LLC | $48.81 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $48.43 | 2019-2024 | Summit Doppler |
| Lupin INC. | $39.87 | 2019-2020 | |
| Avanos Medical | $32.29 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.11 | 2021 | |
| Avion Pharmaceuticals | $28.78 | 2021 | |
| Supernus Pharmaceuticals, INC. | $28.17 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $28.17 | 2025 | Zurzuvae |
| Cumberland Pharmaceuticals, INC. | $26.37 | 2021-2022 | |
| Boston Scientific Corporation | $22.29 | 2025 | Bulkamid |
| Covidien LP | $22.18 | 2019 | |
| Davol INC. | $20.84 | 2019 | |
| Aesculap, INC. | $16.73 | 2019 | |
| Smith+Nephew, INC. | $14.22 | 2019 | |
| Scynexis, INC. | $13.79 | 2021 | |
| Minerva Surgical, INC | $12.00 | 2019 | |
| Urovant Sciences INC | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.